NYSE:HQH

Tekla Healthcare Investors Stock Insider Trading

Financial Services > Asset Management

Buy HQH

*Your capital is at risk

$18.99

-0.170 (-0.89%)

At Close: Jun 03, 2026

Tekla Healthcare Investors Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 124.04M and sold 0 HQH shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	100.00
● Buy	124.04M shares
● Sell	0 shares
100% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 13, 2024 Buy	Common Stock J-Other	Silue Kolotioloma Officer	Officer	0 Value: $0
Mar 13, 2024 Buy	Common Stock J-Other	Silue Kolotioloma Officer	Officer	0 Value: $0
Mar 13, 2024 Buy	Common Stock J-Other	Tse Loretta Officer	Officer	0 Value: $0
Mar 13, 2024 Buy	Common Stock J-Other	Tse Loretta Officer	Officer	0 Value: $0
Jan 02, 2024 Buy	Common Stock P-Purchase	Reit Todd Director	Director	1 000 Value: $16.9K
Jan 02, 2024 Buy	Common Stock P-Purchase	Reit Todd Director	Director	1 000 Value: $16.9K
Dec 28, 2023 Buy	Common Stock P-Purchase	Maher Bill Director	Director	1 000 Value: $16.6K
Dec 28, 2023 Buy	Common Stock P-Purchase	Maher Bill Director	Director	1 000 Value: $16.6K
Dec 21, 2023 Buy	Common stock P-Purchase	Goodson Alan R Vice President	CEO / President	170 Value: $3K
Dec 21, 2023 Buy	Common stock P-Purchase	Goodson Alan R Vice President	CEO / President	170 Value: $3K
Dec 13, 2023 Buy	Common Stock J-Other	Duitz Joshua Officer	Officer	0 Value: $0
Dec 13, 2023 Buy	Common Stock J-Other	Ritchie Ben Officer	Officer	0 Value: $0
Dec 13, 2023 Buy	Common Stock J-Other	Duitz Joshua Officer	Officer	0 Value: $0
Dec 13, 2023 Buy	Common Stock J-Other	Ritchie Ben Officer	Officer	0 Value: $0
Oct 27, 2023 Buy	Common Stock J-Other	Sitar Lucia Officer	Officer	0 Value: $0
Oct 27, 2023 Buy	Common Stock J-Other	Goodson Alan R Officer	Officer	0 Value: $0
Oct 27, 2023 Buy	Common Stock J-Other	Kennedy Megan Officer	Officer	0 Value: $0
Oct 27, 2023 Buy	Common Stock J-Other	Ferrari Sharon Officer	Officer	0 Value: $0
Oct 27, 2023 Buy	Common Stock J-Other	Andolina Joseph Officer	Officer	0 Value: $0
Oct 27, 2023 Buy	Common Stock J-Other	Pittard Christian Officer	Officer	0 Value: $0
Oct 27, 2023 Buy	Common Stock J-Other	Bird Stephen	Director	0 Value: $0
Oct 27, 2023 Buy	Common Stock J-Other	Reit Todd	Director	0 Value: $0
Oct 27, 2023 Buy	Common Stock J-Other	Maher Bill	Director	0 Value: $0
Oct 27, 2023 Buy	Common Stock J-Other	Dimartino Rose	Director	0 Value: $0
Oct 27, 2023 Buy	Common Stock J-Other	Tooze Marika Insider	Other	0 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT TEKLA HEALTHCARE INVESTORS

Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on ...

Read Full Profile Here